The objective of the present study was to develop ¿once daily¿ sustained-release bioadhesive tablet of Zaltoprofen (ZLT) and Lornoxicam (LXM) which will deliver the drug it in small doses over an extended period and localizing it in the intestine by bioadhesion. ZLT is a new non-steroidal anti-inflammatory drug which has anti-inflammatory, analgesic and antipyretic effect and frequently used for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout. ZLT has short biological half-life... Mehr